Table 3.
Complications, treatment, and outcomes of infected patients during hospitalization.
| Patients No. (%) | ||||
|---|---|---|---|---|
| Cardiac injury | ||||
|
All n (%) |
With n (%) |
Without n (%) |
P value | |
| Complications | ||||
| Sepsis | 1,271 (62%) | 411 (66%) | 860 (60%) | <0.0001 |
| ARDS | 677 (33%) | 380 (61%) | 297 (21%) | <0.0001 |
| Respiratory failure | 642 (31%) | 388 (62%) | 254 (18%) | 0.001 |
| Septic shock | 594 (29%) | 295 (47%) | 299 (21%) | 0.05 |
| Bacteremia | 349 (17%) | 225 (36%) | 124 (9%) | 0.48 |
| Hyperglycemia | 329 (16%) | 131 (21%) | 198 (14%) | 0.002 |
| Electrolyte disturbance | 226 (11%) | 126 (20%) | 100 (7%) | 0.054 |
| Anemia | 144 (7%) | 81 (13%) | 63 (4%) | 0.24 |
| Hypoproteinemia | 103 (5%) | 51 (8%) | 52 (4%) | 0.63 |
| Coagulopathy | 83 (4%) | 54 (9%) | 29 (2%) | 0.05 |
| Acidosis | 82 (4%) | 27 (4%) | 55 (4%) | 0.17 |
| Acute kidney injury | 41 (2%) | 19 (3%) | 22 (1%) | 0.09 |
| In-hospital treatment | ||||
| Antibiotic therapy | 1,337 (65%) | 549 (88%) | 788 (55%) | 0.001 |
| Antiviral therapy | 1,932 (94%) | 617 (99%) | 1,315 (92%) | 0.06 |
| Intravenous corticosteroids | 1,601 (78%) | 561 (90%) | 1,040 (73%) | 0.001 |
| High-flow nasal cannula oxygen therapy | 1,436 (70%) | 139 (22%) | 1,297 (91%) | <0.0001 |
| Non-invasive mechanical ventilation | 266 (13%) | 237 (38%) | 29 (2%) | 0.001 |
| Invasive mechanical ventilation | 169 (8%) | 126 (20%) | 43 (3%) | 0.001 |
| ECMO | 21 (1%) | 21 (3%) | 0 | 0.91 |
| CRRT | 41 (2%) | 39 (6%) | 2 (0.14%) | 0.39 |
| Intravenous immunoglobin | 1,338 (65%) | 534 (86%) | 804 (56%) | 0.09 |
| Clinical outcomes | ||||
| Recovered and discharged | 1,717 (84%) | 326 (52%) | 1,391 (97%) | 0.001 |
| In-hospital death | 334 (16%) | 297 (48%) | 37 (2%) | 0.001 |
ARDS, Acute respiratory syndrome; ECMO, Extracorporeal membrane oxygenation; CRRT, Continuous renal replacement therapy. The significance threshold is at <0.05 and <0.01.